Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interventional & Surgical Innovations (ISI) was a venture-funded medical device incubator founded in 2007 by Peter Hinchliffe and Trevi Health Ventures. Based in Campbell Hall, New York, the company specialized in accelerating the development of advanced technologies for general and cardiovascular surgery. Its portfolio included site-specific drug delivery systems, minimally invasive surgical instruments, and vascular implants such as inferior vena cava (IVC) filters and prosthetic venous valves. ISI operated by identifying promising early-stage technologies, providing engineering and clinical expertise, and spinning out successful ventures like Deep Vein Medical. The company also expanded its capabilities through the acquisition of Advantis Medical, focusing on high-performance surgical tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interventional & Surgical Innovations.